+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Transarterial Chemoembolization Market - Global Forecast 2025-2030- Product Image
Transarterial Chemoembolization Market - Global Forecast 2025-2030- Product Image
Sale

Transarterial Chemoembolization Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6085527
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Transarterial Chemoembolization Market is evolving rapidly, driven by innovations in targeted cancer treatment and a strong push for improved procedural outcomes. Senior healthcare leaders require deep, actionable insights to guide investment and operational strategies within this dynamic segment.

Market Snapshot: Transarterial Chemoembolization Market Overview

The Transarterial Chemoembolization Market grew from USD 1.57 billion in 2024 to USD 1.66 billion in 2025. It is expected to continue growing at a CAGR of 5.75%, reaching USD 2.20 billion by 2030. Market expansion is being shaped by increasing adoption of minimally invasive oncologic interventions, ongoing technological advancements, and interdisciplinary collaboration among clinical, procurement, and engineering teams. Improvements in device precision, drug delivery techniques, and real-time imaging are key contributors to sustained market momentum.

Scope & Segmentation

This report delivers a focused analysis designed for high-level decision-making. It details the market along the following axes:

  • Drug Types: Covers the use of cisplatin and doxorubicin, with both drugs remaining foundational to evolving treatment protocols and selection strategies.
  • Indications: Explores applications in liver, breast, and lung cancers, informed by the latest clinical practices and outcomes.
  • Procedure Types: Assesses both conventional TACE methods and newer drug-eluting bead technologies, highlighting implications for workflow and patient management.
  • End-Users: Reviews utilization across hospitals, ambulatory surgical centers, and specialty clinics, emphasizing operational differences and resource prioritization.
  • Geographic Coverage: Analyzes regional dynamics in the Americas, EMEA, and Asia-Pacific, with detailed consideration of healthcare infrastructure, reimbursement trends, and regulatory environments.
  • Leading Companies: Examines competitive positioning and strategies for organizations including AdvaCare Pharma, Cadila Healthcare Limited, Dr. Reddy’s Laboratories Ltd., Johnson & Johnson Services, Inc., LGM Pharma, MicroBiopharm Japan Co., Ltd., Novartis AG, Pfizer Inc., Veranova, L.P., and WG Critical Care, LLC.

Key Takeaways for Decision-Makers

  • Adoption of advanced imaging and targeted drug carriers is enhancing procedure accuracy and enabling more personalized patient management across oncology networks.
  • Continuous clinical and technological collaboration between radiologists, oncologists, and biomedical engineers is streamlining device innovation and protocol development, promoting clinical best practices.
  • Strategic diversification of supplier portfolios is emerging in response to complex trade conditions, ensuring resilience and sustainability within the supply chain for critical materials.
  • Growth in specialized oncology centers, particularly in Asia-Pacific, is expanding market reach and accelerating capacity-building for emerging interventions like TACE.
  • Stakeholders are using digital health platforms and analytics to support remote monitoring, data-driven decision-making, and continuous quality improvement in procedure planning and post-care follow-up.
  • Strategic alliances and service-driven approaches among leading companies are resulting in stronger customer relationships, recurring revenue streams, and enhanced brand presence in the interventional oncology space.

Tariff Impact: Navigating US Trade Adjustments

Recent US tariff changes on medical device and pharmaceutical imports have compelled market participants to optimize sourcing strategies and explore alternative supplier networks. Procurement teams and manufacturers are recalibrating pricing strategies, forming local production partnerships, and promoting transparency in vendor relationships. These adaptations are expected to preserve procedural continuity while catalyzing new supply chain resiliency measures.

Methodology & Data Sources

This report is grounded in a robust methodology combining secondary research, expert interviews, and proprietary data modeling. Analysis integrates peer-reviewed publications, clinical trial data, regulatory filings, and direct perspectives from industry and clinical experts, supported by statistical normalization and qualitative thematic analysis.

Why This Report Matters

  • Provides a comprehensive framework for strategic resource allocation and operational improvement in cancer intervention programs.
  • Enables data-driven, region-specific decision-making for expanding clinical capabilities and entering new growth markets.
  • Supports procurement and executive leaders in identifying actionable paths for supply chain resilience, technology adoption, and service differentiation.

Conclusion

This executive summary equips senior decision-makers with essential market intelligence, highlighting evolving clinical, technical, and competitive trends that will define the trajectory of transarterial chemoembolization. Leaders can rely on these insights for long-term planning and effective implementation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising adoption of drug-eluting bead TACE technologies to improve targeted chemotherapy delivery and reduce systemic toxicity
5.2. Integration of radiomics and artificial intelligence for predictive response assessment and personalized treatment planning in TACE procedures
5.3. Development of combination therapies pairing transarterial chemoembolization with immune checkpoint inhibitors to enhance antitumor efficacy
5.4. Increasing focus on patient-centric outcome measures and quality-of-life assessments to guide TACE therapy optimization
5.5. Expansion of outpatient and hybrid interventional oncology suites to lower hospitalization costs and improve procedural efficiency
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Transarterial Chemoembolization Market, by Drug Type
8.1. Introduction
8.2. Cisplatin
8.3. Doxorubicin
9. Transarterial Chemoembolization Market, by Indication
9.1. Introduction
9.2. Breast Cancer
9.3. Liver Cancer
9.4. Lung Cancer
10. Transarterial Chemoembolization Market, by Procedure Type
10.1. Introduction
10.2. Conventional TACE
10.3. Drug-Eluting Beads
11. Transarterial Chemoembolization Market, by End-User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Transarterial Chemoembolization Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Transarterial Chemoembolization Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Transarterial Chemoembolization Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AdvaCare Pharma
15.3.2. Cadila Healthcare Limited
15.3.3. Dr. Reddy’s Laboratories Ltd.
15.3.4. Johnson & Johnson Services, Inc.
15.3.5. LGM Pharma
15.3.6. MicroBiopharm Japan Co., Ltd.
15.3.7. Novartis AG
15.3.8. Pfizer Inc.
15.3.9. Veranova, L.P.
15.3.10. WG Critical Care, LLC
16. Research AI17. Research Statistics18. Research Contacts19. Research Articles20. Appendix
List of Figures
FIGURE 1. TRANSARTERIAL CHEMOEMBOLIZATION MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. TRANSARTERIAL CHEMOEMBOLIZATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. TRANSARTERIAL CHEMOEMBOLIZATION MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. TRANSARTERIAL CHEMOEMBOLIZATION MARKET: RESEARCHAI
FIGURE 24. TRANSARTERIAL CHEMOEMBOLIZATION MARKET: RESEARCHSTATISTICS
FIGURE 25. TRANSARTERIAL CHEMOEMBOLIZATION MARKET: RESEARCHCONTACTS
FIGURE 26. TRANSARTERIAL CHEMOEMBOLIZATION MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. TRANSARTERIAL CHEMOEMBOLIZATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY CISPLATIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY CISPLATIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DOXORUBICIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DOXORUBICIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY BREAST CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY LIVER CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY CONVENTIONAL TACE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY CONVENTIONAL TACE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 38. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 39. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 40. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 43. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 44. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 45. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 46. AMERICAS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 47. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 48. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 49. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 50. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 51. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 52. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 53. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 54. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 55. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 56. UNITED STATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 57. CANADA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 58. CANADA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 59. CANADA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 60. CANADA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 61. CANADA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 62. CANADA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 63. CANADA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 64. CANADA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 65. MEXICO TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 66. MEXICO TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 67. MEXICO TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 68. MEXICO TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 69. MEXICO TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 70. MEXICO TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 71. MEXICO TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 72. MEXICO TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 73. BRAZIL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 74. BRAZIL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 75. BRAZIL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 76. BRAZIL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 77. BRAZIL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 78. BRAZIL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 79. BRAZIL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 80. BRAZIL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 81. ARGENTINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 82. ARGENTINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 83. ARGENTINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 84. ARGENTINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 85. ARGENTINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 86. ARGENTINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 87. ARGENTINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 88. ARGENTINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 100. UNITED KINGDOM TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED KINGDOM TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED KINGDOM TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 106. UNITED KINGDOM TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 107. GERMANY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 108. GERMANY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 109. GERMANY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 110. GERMANY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 111. GERMANY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 112. GERMANY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 113. GERMANY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 114. GERMANY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 115. FRANCE TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 116. FRANCE TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 117. FRANCE TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. FRANCE TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. FRANCE TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 120. FRANCE TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 121. FRANCE TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 122. FRANCE TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 123. RUSSIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 124. RUSSIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 125. RUSSIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 126. RUSSIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 127. RUSSIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 128. RUSSIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 129. RUSSIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 130. RUSSIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 131. ITALY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 132. ITALY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 133. ITALY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 134. ITALY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 135. ITALY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 136. ITALY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 137. ITALY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 138. ITALY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 139. SPAIN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 140. SPAIN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 141. SPAIN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 142. SPAIN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 143. SPAIN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 144. SPAIN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 145. SPAIN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 146. SPAIN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 156. SAUDI ARABIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 158. SAUDI ARABIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 160. SAUDI ARABIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 162. SAUDI ARABIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 164. SOUTH AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. SOUTH AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 168. SOUTH AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 170. SOUTH AFRICA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 171. DENMARK TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 172. DENMARK TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 173. DENMARK TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 174. DENMARK TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 175. DENMARK TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 176. DENMARK TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 177. DENMARK TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 178. DENMARK TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 179. NETHERLANDS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 180. NETHERLANDS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 181. NETHERLANDS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. NETHERLANDS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. NETHERLANDS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 184. NETHERLANDS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 185. NETHERLANDS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 186. NETHERLANDS TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 187. QATAR TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 188. QATAR TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 189. QATAR TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. QATAR TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. QATAR TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 192. QATAR TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 193. QATAR TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 194. QATAR TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 195. FINLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 196. FINLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 197. FINLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 198. FINLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 199. FINLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 200. FINLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 201. FINLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 202. FINLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 203. SWEDEN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 204. SWEDEN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 205. SWEDEN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. SWEDEN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. SWEDEN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 208. SWEDEN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 209. SWEDEN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 210. SWEDEN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 211. NIGERIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 212. NIGERIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 213. NIGERIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. NIGERIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. NIGERIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 216. NIGERIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 217. NIGERIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 218. NIGERIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 219. EGYPT TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 220. EGYPT TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 221. EGYPT TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 222. EGYPT TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 223. EGYPT TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 224. EGYPT TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 225. EGYPT TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 226. EGYPT TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 227. TURKEY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 228. TURKEY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 229. TURKEY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. TURKEY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. TURKEY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 232. TURKEY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 233. TURKEY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 234. TURKEY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 235. ISRAEL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 236. ISRAEL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 237. ISRAEL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 238. ISRAEL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 239. ISRAEL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 240. ISRAEL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 241. ISRAEL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 242. ISRAEL TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 243. NORWAY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 244. NORWAY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 245. NORWAY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. NORWAY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. NORWAY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 248. NORWAY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 249. NORWAY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 250. NORWAY TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 251. POLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 252. POLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 253. POLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 254. POLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 255. POLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 256. POLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 257. POLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 258. POLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 259. SWITZERLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 260. SWITZERLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 261. SWITZERLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. SWITZERLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. SWITZERLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 264. SWITZERLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 265. SWITZERLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 266. SWITZERLAND TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 268. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 272. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 274. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 276. ASIA-PACIFIC TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 277. CHINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 278. CHINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 279. CHINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 280. CHINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 281. CHINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 282. CHINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 283. CHINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 284. CHINA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 285. INDIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 286. INDIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 287. INDIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. INDIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. INDIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 290. INDIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 291. INDIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 292. INDIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 293. JAPAN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 294. JAPAN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 295. JAPAN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. JAPAN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. JAPAN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 298. JAPAN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 299. JAPAN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 300. JAPAN TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 301. AUSTRALIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 302. AUSTRALIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 303. AUSTRALIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 304. AUSTRALIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 305. AUSTRALIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2018-2024 (USD MILLION)
TABLE 306. AUSTRALIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY PROCEDURE TYPE, 2025-2030 (USD MILLION)
TABLE 307. AUSTRALIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 308. AUSTRALIA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 309. SOUTH KOREA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 310. SOUTH KOREA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 311. SOUTH KOREA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 312. SOUTH KOREA TRANSARTERIAL CHEMOEMBOLIZATION MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 313. SOUTH KOREA TRANSARTERIAL CHEMOEMBOLIZATION

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Transarterial Chemoembolization market report include:
  • AdvaCare Pharma
  • Cadila Healthcare Limited
  • Dr. Reddy’s Laboratories Ltd.
  • Johnson & Johnson Services, Inc.
  • LGM Pharma
  • MicroBiopharm Japan Co., Ltd.
  • Novartis AG
  • Pfizer Inc.
  • Veranova, L.P.
  • WG Critical Care, LLC

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.66 billion
Forecasted Market Value ( USD ) by 2030 $ 2.2 billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Transarterial Chemoembolization - Global Strategic Business Report - Product Image

Transarterial Chemoembolization - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Hepatocellular Carcinoma Epidemiology Forecast 2025-2034 - Product Image

Hepatocellular Carcinoma Epidemiology Forecast 2025-2034

  • Report
  • 150 Pages
  • Global
From
Liver Metastases Treatment Market - Global Forecast 2025-2030 - Product Image

Liver Metastases Treatment Market - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insight, 2025 - Product Image

Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insight, 2025

  • Clinical Trials
  • 180 Pages
  • Global
From
Unresectable Hepatocellular Carcinoma - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Unresectable Hepatocellular Carcinoma - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 129 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.